Skip to main navigation Skip to search Skip to main content

Rare coding variants in ten genes confer substantial risk for schizophrenia

  • Tarjinder Singh
  • , Timothy Poterba
  • , David Curtis
  • , Huda Akil
  • , Mariam Al Eissa
  • , Jack D. Barchas
  • , Nicholas Bass
  • , Tim B. Bigdeli
  • , Gerome Breen
  • , Evelyn J. Bromet
  • , Peter F. Buckley
  • , William E. Bunney
  • , Jonas Bybjerg-Grauholm
  • , William F. Byerley
  • , Sinéad B. Chapman
  • , Wei J. Chen
  • , Claire Churchhouse
  • , Nicholas Craddock
  • , Caroline M. Cusick
  • , Lynn DeLisi
  • Sheila Dodge, Michael A. Escamilla, Saana Eskelinen, Ayman H. Fanous, Stephen V. Faraone, Alessia Fiorentino, Laurent Francioli, Stacey B. Gabriel, Diane Gage, Sarah A. Gagliano Taliun, Andrea Ganna, Giulio Genovese, David C. Glahn, Jakob Grove, Mei Hua Hall, Eija Hämäläinen, Henrike O. Heyne, Matti Holi, David M. Hougaard, Daniel P. Howrigan, Hailiang Huang, Hai Gwo Hwu, René S. Kahn, Hyun Min Kang, Konrad J. Karczewski, George Kirov, James A. Knowles, Francis S. Lee, Douglas S. Lehrer, Francesco Lescai, Dolores Malaspina, Stephen R. Marder, Steven A. McCarroll, Andrew M. McIntosh, Helena Medeiros, Lili Milani, Christopher P. Morley, Derek W. Morris, Preben Bo Mortensen, Richard M. Myers, Merete Nordentoft, Niamh L. O’Brien, Ana Maria Olivares, Dost Ongur, Willem H. Ouwehand, Duncan S. Palmer, Tiina Paunio, Digby Quested, Mark H. Rapaport, Elliott Rees, Brandi Rollins, F. Kyle Satterstrom, Alan Schatzberg, Edward Scolnick, Laura J. Scott, Sally I. Sharp, Pamela Sklar, Jordan W. Smoller, Janet L. Sobell, Matthew Solomonson, Eli A. Stahl, Christine R. Stevens, Jaana Suvisaari, Grace Tiao, Stanley J. Watson, Nicholas A. Watts, Douglas H. Blackwood, Anders D. Børglum, Bruce M. Cohen, Aiden P. Corvin, Tõnu Esko, Nelson B. Freimer, Stephen J. Glatt, Christina M. Hultman, Andrew McQuillin, Aarno Palotie, Carlos N. Pato, Michele T. Pato, Ann E. Pulver, David St. Clair, Ming T. Tsuang, Marquis P. Vawter, James T. Walters, Thomas M. Werge, Roel A. Ophoff, Patrick F. Sullivan, Michael J. Owen, Michael Boehnke, Michael C. O’Donovan, Benjamin M. Neale, Mark J. Daly
  • Massachusetts General Hospital
  • Broad Institute
  • University College London
  • Queen Mary University of London
  • University of Michigan Medical School
  • Joan and Sanford I. Weill Department of Medicine
  • SUNY Downstate Medical Center
  • King's College London
  • Stony Brook University
  • Virginia Commonwealth University
  • University of California
  • IPSYCH
  • Statens Serum Institut
  • University of California San Francisco
  • National Taiwan University
  • Cardiff University
  • Cambridge Hospital
  • Texas Tech University Health Sciences Center El Paso
  • University of Helsinki
  • Finnish Institute for Health and Welfare - THL
  • SUNY Upstate Medical University
  • Université de Montréal, Faculté de Médecine
  • Université de Montréal
  • Boston Children's Hospital
  • Aarhus University
  • Center for Genomics and Personalized Medicine
  • Harvard Medical School
  • Helsinki University Central Hospital
  • Icahn School of Medicine at Mount Sinai
  • James J. Peters VA Medical Center
  • University of Michigan School of Public Health
  • Wright State University Boonshoft School of Medicine
  • University of Edinburgh
  • University of Tartu
  • State University of New York
  • HudsonAlpha Institute for Biotechnology
  • Copenhagen University Hospital
  • University of Copenhagen
  • University of Cambridge
  • Oxford Health NHS Foundation Trust
  • Emory University School of Medicine
  • Stanford University School of Medicine
  • Keck School of Medicine of USC
  • Trinity College Dublin
  • Karolinska Institutet
  • The Johns Hopkins University School of Medicine
  • University of Aberdeen
  • University of California San Diego
  • University of California
  • Erasmus MC
  • University of North Carolina

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

665 Citations (Scopus)

Abstract

Rare coding variation has historically provided the most direct connections between gene function and disease pathogenesis. By meta-analysing the whole exomes of 24,248 schizophrenia cases and 97,322 controls, we implicate ultra-rare coding variants (URVs) in 10 genes as conferring substantial risk for schizophrenia (odds ratios of 3–50, P < 2.14 × 10−6) and 32 genes at a false discovery rate of <5%. These genes have the greatest expression in central nervous system neurons and have diverse molecular functions that include the formation, structure and function of the synapse. The associations of the NMDA (N-methyl-d-aspartate) receptor subunit GRIN2A and AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor subunit GRIA3 provide support for dysfunction of the glutamatergic system as a mechanistic hypothesis in the pathogenesis of schizophrenia. We observe an overlap of rare variant risk among schizophrenia, autism spectrum disorders1, epilepsy and severe neurodevelopmental disorders2, although different mutation types are implicated in some shared genes. Most genes described here, however, are not implicated in neurodevelopment. We demonstrate that genes prioritized from common variant analyses of schizophrenia are enriched in rare variant risk3, suggesting that common and rare genetic risk factors converge at least partially on the same underlying pathogenic biological processes. Even after excluding significantly associated genes, schizophrenia cases still carry a substantial excess of URVs, which indicates that more risk genes await discovery using this approach.

Original languageEnglish
Pages (from-to)509-516
Number of pages8
JournalNature
Volume604
Issue number7906
DOIs
Publication statusPublished - 21 Apr 2022

Fingerprint

Dive into the research topics of 'Rare coding variants in ten genes confer substantial risk for schizophrenia'. Together they form a unique fingerprint.

Cite this